Webster Bank’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-376
Closed -$37K – 565
2017
Q3
$37K Sell
376
-6
-2% -$582 0.01% 386
2017
Q2
$39K Sell
382
-8
-2% -$863 0.01% 373
2017
Q1
$45K Sell
390
-170
-30% -$19.8K 0.01% 372
2016
Q4
$68K Buy
+560
New +$62K 0.01% 319

Other funds holding CLB

Webster Bank's CLB Position: Q4 2017 in Review

Webster Bank sold out of Core Laboratories (CLB) in Q4 2017, closing a stake of 376 shares — an estimated $37K sold.

Webster Bank first reported a position in CLB in Q4 2016 and held it in 4 quarters. The position peaked at $68K in Q4 2016. 356 funds tracked by Wall St. Rank hold CLB as of Q4 2017.

  • Webster Bank reported no remaining Core Laboratories position as of Q4 2017 after selling out during the quarter.
  • Webster Bank sold 376 Core Laboratories shares in Q4 2017, an estimated $37K.
  • Webster Bank first reported a position in Core Laboratories in Q4 2016 and held it in 4 quarters.
  • Webster Bank's Core Laboratories position peaked at $68K in Q4 2016.
  • 356 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2017.

Based on Webster Bank's 13F filing for Q4 2017, filed 23 Jan 2018.